Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,614.17%83.72M | 1,474.61%92.54M | 1,059.83%91.16M | 88.00%45.89M | 677.92%27.27M | 0.14%4.88M | -5.15%5.88M | -20.04%7.86M | 0.20%24.41M | 3.51M |
| Cost of revenue | 3,354.45%77.59M | 2,669.92%88.58M | 2,112.30%86.35M | 155.56%34.5M | 959.80%25.15M | -7.46%2.25M | -8.31%3.2M | -25.10%3.9M | 5.80%13.5M | 2.37M |
| Gross profit | 132.49%6.13M | 47.74%3.96M | 21.73%4.82M | 4.40%11.39M | 87.01%2.12M | 7.67%2.64M | -1.07%2.68M | -14.33%3.96M | -5.96%10.91M | 1.13M |
| Operating expense | -14.94%1.6M | -112.36%-188K | -28.65%991K | 42.23%7.52M | 183.75%2.72M | 24.82%1.88M | -26.84%1.52M | 88.21%1.39M | -0.54%5.28M | 960K |
| Selling and administrative expenses | 11.31%2.22M | 99.02%3.25M | 7.99%1.72M | 37.01%7.88M | 139.36%2.82M | 32.23%2M | -27.12%1.63M | 100.13%1.59M | 2.47%5.75M | --1.18M |
| -Selling and marketing expense | -10.48%94K | 2.17%94K | -30.07%107K | 43.93%368.99K | -75.00%19K | 38.16%105K | -14.02%92K | 378.13%153K | 31.69%256.37K | --76K |
| -General and administrative expense | 12.52%2.13M | 104.81%3.15M | 12.05%1.61M | 36.69%7.51M | 154.13%2.8M | 31.92%1.89M | -27.78%1.54M | 88.45%1.44M | 1.42%5.49M | --1.1M |
| Total other operating income | 433.33%624K | 3,021.82%3.43M | 262.50%725K | -21.98%364.26K | -55.25%98K | 2,825.00%117K | -30.82%110K | 257.14%200K | 55.83%466.86K | --219K |
| Operating profit | 498.81%4.53M | 258.03%4.15M | 48.99%3.83M | -31.12%3.88M | -452.91%-607K | -19.72%757K | 84.10%1.16M | -33.83%2.57M | -10.55%5.63M | 172K |
| Net non-operating interest income (expenses) | -374.05%-433K | -390.42%-485K | -309.03%-324K | 59.20%521.85K | -73.75%42K | -5.95%158K | 695.24%167K | 838.10%155K | 438.85%327.81K | 160K |
| Non-operating interest income | -22.86%135K | -21.47%139K | -11.54%161K | 31.02%678.51K | -33.33%144K | -17.45%175K | 168.18%177K | 658.33%182K | 699.40%517.85K | --216K |
| Non-operating interest expense | 3,241.18%568K | 6,140.00%624K | 1,696.30%485K | -17.57%156.66K | 82.14%102K | -61.36%17K | -77.78%10K | -40.00%27K | 17.66%190.04K | --56K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 348.09%4.1M | 176.30%3.66M | 28.61%3.5M | -26.15%4.4M | -270.18%-565K | -17.64%915K | 103.85%1.33M | -29.46%2.72M | -3.86%5.95M | 332K |
| Income tax | 123.59%673K | -4.07%424K | 2.48%992K | -75.11%477.34K | -964.83%-1.25M | -26.59%301K | -14.84%442K | 14.83%968K | 154.43%1.92M | 145K |
| Net income | 458.14%3.43M | 266.59%3.24M | 43.02%2.51M | -2.89%3.92M | 268.45%689K | -12.41%614K | 574.05%883K | -41.83%1.76M | -25.79%4.04M | 187K |
| Net income continuous operations | 458.14%3.43M | 266.59%3.24M | 43.02%2.51M | -2.89%3.92M | 268.45%689K | -12.41%614K | 574.05%883K | -41.83%1.76M | -25.79%4.04M | --187K |
| Noncontrolling interests | 0 | 0 | -95.49K | 69K | 82K | 0 | ||||
| Net income attributable to the company | 528.81%3.43M | 304.12%3.24M | 43.02%2.51M | -0.52%4.02M | 268.45%689K | -22.25%545K | 511.45%801K | -41.83%1.76M | -25.79%4.04M | 187K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 528.81%3.43M | 304.12%3.24M | 43.02%2.51M | -0.52%4.02M | 268.45%689K | -22.25%545K | 511.45%801K | -41.83%1.76M | -25.79%4.04M | 187K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 433.33%0.0064 | 258.82%0.0061 | 42.42%0.0047 | -8.54%0.0075 | 225.00%0.0013 | -7.69%0.0012 | 750.00%0.0017 | -41.75%0.0033 | -19.71%0.0082 | 0.0004 |
| Diluted earnings per share | 433.33%0.0064 | 258.82%0.0061 | 42.42%0.0047 | -8.54%0.0075 | 225.00%0.0013 | -7.69%0.0012 | 750.00%0.0017 | -41.75%0.0033 | -19.71%0.0082 | 0.0004 |
| Dividend per share | 0 | 0 | 0.002 | |||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.